Acrivon Therapeutics SWOT analysis oncology biotech stocks platform potential
SBHMY Stock | USD 8.06 0.00 0.00% |
Slightly above 62% of Sino Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading Sino Biopharmaceutical Ltd pink sheet suggests that many investors are alarmed at this time. Sino Biopharmaceutica's investing sentiment can be driven by a variety of factors including economic data, Sino Biopharmaceutica's earnings reports, geopolitical events, and overall market trends.
Sino |
Acrivon Therapeutics SWOT analysis oncology biotech stocks platform potential
Read at investing.com
![]() |
Sino Biopharmaceutica Fundamental Analysis
We analyze Sino Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sino Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sino Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Sino Biopharmaceutica is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Sino Biopharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sino Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of Sino Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Sino Biopharmaceutica by comparing valuation metrics with similar companies.
Peers
Sino Biopharmaceutica Related Equities
PTIX | Protagenic Therapeutics | 31.46 | ||||
ENLV | Enlivex Therapeutics | 5.88 | ||||
CNTA | Centessa Pharmaceuticals | 5.02 | ||||
ACRV | Acrivon Therapeutics, | 4.28 | ||||
TARS | Tarsus Pharmaceuticals | 4.17 | ||||
GNFT | Genfit | 2.06 | ||||
KZR | Kezar Life | 1.75 | ||||
NUVL | Nuvalent | 0.82 | ||||
TPST | Tempest Therapeutics | 0.19 | ||||
RNXT | RenovoRx | 0.98 | ||||
XOMA | XOMA Corp | 2.33 | ||||
ELDN | Eledon Pharmaceuticals | 2.99 | ||||
TRDA | Entrada Therapeutics | 3.00 | ||||
FENC | Fennec Pharmaceuticals | 4.13 | ||||
ANEB | Anebulo Pharmaceuticals | 5.41 | ||||
ACXP | Acurx Pharmaceuticals | 6.96 | ||||
DTCFF | Defence Therapeutics | 9.20 | ||||
OPT | Opthea | 20.76 |
Additional Tools for Sino Pink Sheet Analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.